Ebola vaccine performs well in U.K. human trial

Ebola trial participant getting vaccinated

An experimental vaccine against Ebola is relatively safe in humans, a U.K.-based study of 60 people finds. A trial of another vaccine (shown being administered above) produced similar results in 20 patients in a National Institutes of Health study in September.

NIAID (CC BY 2.0)

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content